Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Ebiomedicine|July 15, 2023
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.Ebiomedicine|October 12, 2024
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.Ebiomedicine|May 9, 2026
Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunityPuran Chen, Peter Bergman, Ola Blennow, et al.Med (New York, N.Y.)|January 25, 2022
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individualsKatie Healy, Elisa Pin, Puran Chen, et al.Ebiomedicine|December 3, 2021
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trialPeter Bergman, Ola Blennow, Lotta Hansson, et al.Cell|September 27, 2020
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19Takuya Sekine, André Perez-Potti, Olga Rivera-Ballesteros, et al.Molecular Medicine (Cambridge, Mass.)|February 9, 2022
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individualsAngelica Cuapio, Caroline Boulouis, Iva Filipovic, et al.Immunity|August 12, 2022
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccinationYu Gao, Curtis Cai, David Wullimann, et al.Clinical & Translational Immunology|July 23, 2021
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assaySophia Hober, Cecilia Hellström, Jennie Olofsson, et al.Pageof 3